- Q1 2022 Endo International PLC Earnings Call TranscriptMay 06, 2022$1.42 (-29.70%)Earnings
- Q4 2021 Endo International PLC Earnings Call TranscriptMar 01, 2022$2.41 (-22.51%)Earnings
- Endo International PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Endo International PLC Earnings Call TranscriptNov 05, 2021$6.18 (+25.10%)Earnings
- Q2 2021 Endo International PLC Earnings Call TranscriptAug 06, 2021$4.31 (-8.10%)Earnings
- Endo International PLC at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Q1 2021 Endo International PLC Earnings Call TranscriptMay 07, 2021$5.63 (+3.68%)Earnings
- Endo International PLC at JPMorgan Global High Yield & Leveraged Finance Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Endo International PLC Earnings Call TranscriptFeb 26, 2021$7.93 (-14.82%)Earnings
- Endo International PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Endo International PLC at Bank of America Leveraged Finance Virtual Conference TranscriptNov 30, 2020
- Q3 2020 Endo International PLC Earnings Call TranscriptNov 06, 2020$4.48 (-8.01%)Earnings
- Q2 2020 Endo International PLC Earnings Call TranscriptAug 06, 2020$3.54 (-1.94%)Earnings
- Q1 2020 Endo International PLC Earnings Call TranscriptMay 07, 2020$4.16 (-0.72%)Earnings
- Q4 2019 Endo International PLC Earnings Call TranscriptFeb 26, 2020$6.35 (-2.76%)Earnings
- Endo International PLC at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Endo International PLC at Bank of America Merrill Lynch Leveraged Finance Conference TranscriptDec 03, 2019
- Q3 2019 Endo International PLC Earnings Call TranscriptNov 05, 2019$4.45 (-8.44%)Earnings
- Q2 2019 Endo International PLC Earnings Call TranscriptAug 06, 2019$2.25 (-21.05%)Earnings
- Q1 2019 Endo International PLC Earnings Call TranscriptMay 09, 2019$8.01 (-1.96%)Earnings
- Q4 2018 Endo International PLC Earnings Call TranscriptFeb 28, 2019$10.99 (+6.29%)Earnings
Endo International PLC at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. Thanks for joining us. I am Dan Busby, the pharmaceuticals analyst at RBC Capital Markets. And our next company presenting today is Endo International. I'm joined this morning by Blaise Coleman, President and CEO; and Pat Barry, EVP and President of Global Commercial Operations.
Blaise, there's a lot to cover across your branded, specialty injectable, and generic businesses, including the recent launch of Qwo, which I certainly have some questions on, but I'd like to start with a more high-level question.
A lot has changed in the US over the past few months as more people have been vaccinated and the economy continues to reopen. Can you talk about how the pandemic has affected your business to date and how you expect the reopening process to influence the Company over the remainder of 2021?
Sure. Well first off, Dan, it's great to be here with you. Good morning to everybody listening. We really appreciate those joining
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)